MEI Pharma Revenue 2006-2020 | MEIP

MEI Pharma revenue from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
MEI Pharma Annual Revenue
(Millions of US $)
2019 $5
2018 $2
2017 $23
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
2008 $1
2007 $1
2006 $0
2005 $0
MEI Pharma Quarterly Revenue
(Millions of US $)
2020-03-31 $1
2019-12-31 $1
2019-09-30 $1
2019-06-30 $1
2019-03-31 $1
2018-12-31 $2
2018-09-30 $0
2018-06-30 $1
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $5
2016-12-31 $17
2016-09-30 $1
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30 $0
2009-06-30
2009-03-31 $0
2008-12-31 $0
2008-09-30 $0
2008-06-30 $0
2008-03-31 $0
2007-12-31 $0
2007-09-30 $0
2007-06-30 $0
2007-03-31 $0
2006-12-31 $0
2006-09-30 $0
2006-06-30 $0
2006-03-31 $0
2005-12-31 $0
2005-09-30 $0
2005-06-30 $0
2005-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.395B $0.005B
MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards, Inc., is based in San Diego.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.971B 38.01
Takeda Pharmaceutical (TAK) Japan $58.578B 10.27
Astellas Pharma (ALPMY) Japan $32.167B 16.07
Eisai (ESALY) Japan $23.844B 44.42
UCB SA (UCBJF) Belgium $19.723B 0.00
Merck (MKGAF) Germany $15.251B 20.00
Grifols, S.A (GRFS) Spain $13.765B 17.11
Catalent (CTLT) United States $11.571B 44.73
Neurocrine Biosciences (NBIX) United States $10.759B 49.73
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $8.019B 42.64
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.270B 0.00
Orion OYJ (ORINY) Finland $6.978B 31.27
IPSEN SA ADR (IPSEY) France $6.836B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.676B 10.69
United Therapeutics (UTHR) United States $5.442B 10.31
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Hypermarcas (HYPMY) Brazil $4.362B 13.27
Evotec AG (EVTCY) Germany $4.119B 66.40
Nektar Therapeutics (NKTR) United States $3.964B 0.00
ChemoCentryx (CCXI) United States $3.711B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.467B 378.56
PTC Therapeutics (PTCT) United States $3.174B 0.00
FibroGen (FGEN) United States $2.908B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.603B 10.70
Cronos Group (CRON) Canada $2.302B 66.00
Pacira BioSciences (PCRX) United States $2.045B 41.85
Sage Therapeutics (SAGE) United States $1.880B 0.00
USANA Health Sciences (USNA) United States $1.805B 18.52
Heron Therapeutics (HRTX) United States $1.748B 0.00
Xencor (XNCR) United States $1.710B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.686B 0.00
Zogenix (ZGNX) United States $1.659B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.630B 0.00
Corcept Therapeutics (CORT) United States $1.626B 16.13
Ironwood Pharmaceuticals (IRWD) United States $1.584B 12.12
Akebia Therapeutics (AKBA) United States $1.557B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.482B 15.97
Portola Pharmaceuticals (PTLA) United States $1.406B 0.00
Karyopharm Therapeutics (KPTI) United States $1.296B 0.00
Esperion Therapeutics (ESPR) United States $1.252B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Tilray (TLRY) Canada $1.184B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.015B 45.29
Endo (ENDP) Ireland $0.972B 1.51
Translate Bio (TBIO) United States $0.935B 0.00
ImmunoGen (IMGN) United States $0.794B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.736B 0.00
Indivior (INVVY) United States $0.718B 8.91
Aerie Pharmaceuticals (AERI) United States $0.700B 0.00
Collegium Pharmaceutical (COLL) United States $0.676B 0.00
Molecular Templates (MTEM) United States $0.651B 0.00
Radius Health (RDUS) United States $0.616B 0.00
Ardelyx (ARDX) United States $0.615B 0.00
Trillium Therapeutics (TRIL) Canada $0.597B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.525B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.499B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.483B 0.00
Flexion Therapeutics (FLXN) United States $0.474B 0.00
DURECT (DRRX) United States $0.472B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.464B 11.21
Organogenesis Holdings (ORGO) United States $0.461B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.441B 17.21
Harpoon Therapeutics (HARP) United States $0.429B 0.00
Ocular Therapeutix (OCUL) United States $0.386B 0.00
Calithera Biosciences (CALA) United States $0.374B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.359B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.326B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.324B 0.00
TherapeuticsMD (TXMD) United States $0.321B 0.00
Lannett Co Inc (LCI) United States $0.320B 7.02
Avadel Pharmaceuticals (AVDL) Ireland $0.314B 0.00
Concert Pharmaceuticals (CNCE) United States $0.278B 0.00
CASI Pharmaceuticals (CASI) United States $0.269B 0.00
Rafael Holdings (RFL) United States $0.269B 0.00
OptiNose (OPTN) United States $0.246B 0.00
Redhill Biopharma (RDHL) Israel $0.241B 0.00
Jounce Therapeutics (JNCE) United States $0.221B 5.27
KalVista Pharmaceuticals (KALV) United States $0.209B 0.00
PROFOUND MEDICL (PROF) Canada $0.207B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 25.44
Xeris Pharmaceuticals (XERS) United States $0.182B 0.00
Taiwan Liposome (TLC) Taiwan $0.180B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
IMV INC (IMV) Canada $0.178B 0.00
Aquestive Therapeutics (AQST) United States $0.173B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.171B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Altimmune (ALT) United States $0.117B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.117B 0.00
Recro Pharma (REPH) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.113B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.109B 0.00
Champions Oncology (CSBR) United States $0.107B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.104B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.097B 0.00
Otonomy (OTIC) United States $0.091B 0.00
Sundial Growers (SNDL) Canada $0.088B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.081B 0.00
CTI BioPharma (CTIC) United States $0.080B 0.00
Onconova Therapeutics (ONTX) United States $0.080B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.076B 0.00
CV Sciences (CVSI) United States $0.075B 0.00
Hemispherx BioPharma (AIM) United States $0.074B 0.00
Heat Biologics (HTBX) United States $0.073B 0.00
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.060B 0.00
MediWound (MDWD) Israel $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Biomerica (BMRA) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 31.55
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.050B 106.36
Natural Alternatives (NAII) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.048B 0.00
IsoRay (ISR) United States $0.048B 0.00
GTx (ONCT) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
PolarityTE (PTE) United States $0.044B 0.00
Lipocine (LPCN) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 7.47
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
Novan (NOVN) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Shineco (TYHT) China $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00